Search

everythinglearnresearchcommunity

for

Search:↓

Infections during JAK inhibitor treatment for alopecia areata are usually manageable and rarely stop treatment permanently.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Substance P helps restore skin thickness and cell renewal when sensory nerves are reduced.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Researchers found a new mutation in the LIPH gene of a woman with a rare hair condition.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

JAK inhibitors may help improve symptoms in adults with APECED.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Upadacitinib may effectively treat alopecia areata without side effects.

The fuzzy gene is crucial for controlling hair growth cycles.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

The 736T>A mutation in the LIPH gene is common in Japanese people with autosomal recessive woolly hair.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

*Acorus calamus* has many medicinal benefits but needs more safety research.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Higher apelin-12 levels may indicate more severe acne.

An 8-year-old Saudi boy was diagnosed with a rare genetic disorder causing hair loss, skin issues, and light sensitivity.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.